You are here:
Pharmaceuticals in India
#Pharmaceuticals in India
Get Alerts

Articles

View all

100% FDI in pharma sector bad for country: Parl committee

Aug 15, 2013

100% FDI in pharma sector bad for country: Parl committee

The Parliamentary Committee on Commerce on FDI in the pharmaceutical sector has asked the government to impose a blanket ban on foreign investment in brownfield pharma projects. #ToTheContrary #Pharmaceuticals in India #Foreign direct investment #FDI #FDI in Pharma #Parliamentary Committee on Commerce on FDI
Ranbaxy issue a wake up call for Indian pharma firms: Kiran Mazumdar-Shaw

Jun 09, 2013

Ranbaxy issue a wake up call for Indian pharma firms: Kiran Mazumdar-Shaw

The $500 million fine on Ranbaxy by US authorities after it pleaded guilty to "felony charges" for violating drug manufacturing norms is "a wake up call" for Indian pharmaceutical industry, according to Biocon Chairman and Manging Director Kiran Mazumdar-Shaw. #Pharmaceuticals in India #TheySaidIt #Ranbaxy #Kiran Mazumdar-Shaw
'New drug policy to negatively impact investment in pharmas'

May 17, 2013

'New drug policy to negatively impact investment in pharmas'

"At a company level, we were aware of the upcoming policy and have factored in the impact which is likely to be in the range of 3-4 per cent of our finished dosage sales in India. We have plans in place to ride over this impact," Dr Reddy's Laboratories Vice-Chairman and MD Satish Reddy said. #Pharmaceuticals in India #WhoSaidWhat #Dr. Reddy's Laboratories #drug policy
IT services, pharma likely to be biggest employers in 2013

Dec 27, 2012

IT services, pharma likely to be biggest employers in 2013

Information Technology services and pharmaceuticals are likely to drive hiring growth in 2013, to fill mid and senior positions, said HeadHonchos.com, a leading job search and career management portal. #Pharmaceuticals in India #jobs #Employment #Information technology #2013 #FastForward2013
'Patent drug prices should be set after negotiations with pharma cos'

Sep 07, 2012

'Patent drug prices should be set after negotiations with pharma cos'

According to industry estimates, there are around 18 patented drugs being marketed in India with a total market value of around Rs 4,000 crore to Rs 5,000 crore, about 12 percent of the overall domestic market #Pharmaceuticals in India #ToWhatEffect #parliamentary panel #Drug companies

Wire

View all

'Patent drug prices should be set after negotiations with pharma cos'

Jul 01, 2014

Will India Be the Uber of the Pharmaceutical Industry?

Many self-styled libertarians have been celebrating the rise of Uber. Their story is that Uber is a dynamic start-up that has managed to disrupt the moribund cab industry. The company now has a market capitalization of $17 billion. While Uber's marke... #India #Uber
'Patent drug prices should be set after negotiations with pharma cos'

Jun 27, 2014

Exempt biotech, pharma from service tax, MAT: Kiran Mazumdar Shaw

Kiran Mazumdar Shaw, CMD, Biocon, has backed for a conducive policy regime to attract higher investments in India's pharmaceutical and biotech sectors. India's pharma and biotech industry has the potential to generate combined revenues of $100 billio... #India #Kiran Mazumdar-Shaw #Biocon